Murali Chebrolu, PhD

Murali, appointed as Director at Devsynthesis in January 2022, brings over 14 years of expertise in synthetic organic chemistry. His career includes roles at Aurigene Pharmaceuticals, Sapala Organics, Syngene International, and Sai Life Sciences. With a strong background in drug discovery and scale-up processes, Murali's experience contributes to Devsynthesis' commitment to innovative solutions in pharmaceutical R&D and manufacturing.

Education :

• PhD in Chemistry, CSIR-National Chemical Laboratory, Pune, India, demonstrating a strong academic foundation.
• Further enhancing his research capabilities, he pursued post-doctoral research at Kaohsiung Medical University, Kaohsiung, Taiwan.
• Murali's educational journey reflects a commitment to advancing knowledge in the field of chemistry, laying the groundwork for his successful industrial career.